Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenshuai Nutrition Capsule is a Traditional Chinese Medicine (TCM) formulation developed by the Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine. It is primarily investigated for the treatment of protein-energy wasting (PEW) in patients with chronic kidney disease (CKD). The capsule is designed to modulate the intestinal microecology, which is often disrupted in CKD-PEW patients. Research suggests that the therapeutic effect may be mediated through the regulation of targeted intestinal flora, potentially improving nutritional status and slowing disease progression. It is currently being evaluated in clinical research that utilizes machine learning models to assess therapeutic outcomes and clarify the correlation between gut microbiota and CKD-PEW.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenshuai Nutrition Capsule.